|
3UON
Structure of the human M2 muscarinic acetylcholine receptor bound to an antagonist
Deposited 2011-11-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
1–217(217 aa)
Fragment:UNP RESIDUES 1-217, UNP RESIDUES 2-161, UNP RESIDUES 377-466
Chain A
377–466(90 aa)
Fragment:UNP RESIDUES 1-217, UNP RESIDUES 2-161, UNP RESIDUES 377-466
|
Mutation:N2D, N3D, N6D, N9D, C54T, C97A
Mutation:N2D, N3D, N6D, N9D, C54T, C97A
|
QNB (3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate × 1
BGC beta-D-glucopyranose × 1
CL CHLORIDE ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7.5;293 K;25 to 35% PEG 300, 100 mM ammonium phosphate, 2% 2-Methyl-2,4-pentanediol, 100 mM HEPES, 10:1 monoolein:cholesterol lipid mix diluted 1.5:1 with protein in detergent buffer, Lipidic cubic phase, temperature 293K, pH 7.5
|
Resolution 3.00 Å
R-free 0.276
|
|
4MQS
Structure of active human M2 muscarinic acetylcholine receptor bound to the agonist iperoxo
Deposited 2013-09-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–232(232 aa)
Fragment:UNP residues 1-232, 373-466
Chain A
373–466(94 aa)
Fragment:UNP residues 1-232, 373-466
|
Mutation:N0D, N1D, N4D, N7D, A373T, K374R
Mutation:N0D, N1D, N4D, N7D, A373T, K374R
|
IXO 4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethylbut-2-yn-1-aminium × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;Reconstituted in 10:1 monoolein:cholesterol mix. Precipitant solution: 10 - 20% PEG300, 100 mM HEPES, pH 7.2 - 7.9, 1.2% 1,2,3-heptanetriol, and 20 - 80 mM EDTA, pH 8.0, Lipidic cubic phase, temperature 293K
|
Resolution 3.50 Å
R-free 0.298
|
|
4MQT
Structure of active human M2 muscarinic acetylcholine receptor bound to the agonist iperoxo and allosteric modulator LY2119620
Deposited 2013-09-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–232(232 aa)
Fragment:UNP residues 1-232,373-466
Chain A
373–466(94 aa)
Fragment:UNP residues 1-232,373-466
|
Mutation:N0D, N1D, N4D, N7D, A373T, K374R
Mutation:N0D, N1D, N4D, N7D, A373T, K374R
|
IXO 4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethylbut-2-yn-1-aminium × 1
2CU 3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;Reconstituted in 10:1 monoolein:cholesterol mix. Precipitant solution: 0.5 mM LY2119620, 10 - 20% PEG300, 100 mM HEPES pH 7.2 - 7.9, 1.2% 1,2,3-heptanetriol, and 20 - 80 mM EDTA pH 8.0, Lipidic cubic phase, temperature 293K
|
Resolution 3.70 Å
R-free 0.301
|
|
5YC8
Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with NMS (Hg-derivative)
Deposited 2017-09-06
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
10–214(205 aa)
Fragment:UNP residues 10-214,UNP residues 377-466
Chain A
377–466(90 aa)
Fragment:UNP residues 10-214,UNP residues 377-466
|
Mutation:S110R
Mutation:S110R
|
3C0 N-methyl scopolamine × 1
HG MERCURY (II) ION × 3
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;50mM MES-NaOH pH 6.2-7.0, 26-32% PEG300, 300~500mM Ammonium Fluoride, 1% 1,2,3-heptanetriol, 0.5mM NMS and 5% DMSO, 1mM HgCl2
|
Resolution 2.50 Å
R-free 0.270
|
|
5ZK3
Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with QNB
Deposited 2018-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
10–217(208 aa)
Fragment:UNP residues 10-217,UNP residues 377-466
Chain A
377–466(90 aa)
Fragment:UNP residues 10-217,UNP residues 377-466
|
Mutation:S110R
Mutation:S110R
|
QNB (3R)-1-azabicyclo[2.2.2]oct-3-yl hydroxy(diphenyl)acetate × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;50mM MES-NaOH pH 6.2-7.0, 26-32% PEG300, 300~500mM Ammonium Fluoride, 1% 1,2,3-heptanetriol, 0.5mM QNB and 5% DMSO
|
Resolution 2.60 Å
R-free 0.291
|
|
5ZK8
Crystal structure of M2 muscarinic acetylcholine receptor bound with NMS
Deposited 2018-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
10–217(208 aa)
Fragment:UNP residues 10-217,UNP residues 377-466
Chain A
377–466(90 aa)
Fragment:UNP residues 10-217,UNP residues 377-466
|
Not recorded
|
3C0 N-methyl scopolamine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;50mM MES-NaOH pH 6.2-7.0, 26-32 % PEG300, 300~500mM Ammonium Fluoride, 1% 1,2,3-heptanetriol, 0.5mM NMS and 5% DMSO
|
Resolution 3.00 Å
R-free 0.270
|
|
5ZKB
Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with AF-DX 384
Deposited 2018-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
10–217(208 aa)
Fragment:UNP residues 10-217,UNP residues 377-466
Chain A
377–466(90 aa)
Fragment:UNP residues 10-217,UNP residues 377-466
|
Mutation:S110R
Mutation:S110R
|
82F N-[2-[(2S)-2-[(dipropylamino)methyl]piperidin-1-yl]ethyl]-6-oxidanylidene-5H-pyrido[2,3-b][1,4]benzodiazepine-11-carboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;50mM MES-NaOH pH 6.2-7.0, 18 % PEG300, 100mM Magnesium acetate, 1% 1,2,3-heptanetriol, 0.5mM AF-DX 384 and 5% DMSO
|
Resolution 2.95 Å
R-free 0.280
|
|
5ZKC
Crystal structure of rationally thermostabilized M2 muscarinic acetylcholine receptor bound with NMS
Deposited 2018-03-23
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental method
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
10–217(208 aa)
Fragment:UNP residues 10-217,UNP residues 377-466
Chain A
377–466(90 aa)
Fragment:UNP residues 10-217,UNP residues 377-466
|
Mutation:S110R
Mutation:S110R
|
3C0 N-methyl scopolamine × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;293 K;50mM MES-NaOH pH 6.2-7.0, 26-32 % PEG300, 300~500mM Ammonium Fluoride, 1% 1,2,3-heptanetriol, 0.5mM NMS and 5% DMSO
|
Resolution 2.30 Å
R-free 0.259
|
|
6OIK
Muscarinic acetylcholine receptor 2-Go complex
Deposited 2019-04-09
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain R
3–232(230 aa)
Chain R
360–466(107 aa)
|
Mutation:N8A, N11D, N14D,N11D, N14D
Mutation:N8A, N11D, N14D,N11D, N14D
|
IXO 4-(4,5-dihydro-1,2-oxazol-3-yloxy)-N,N,N-trimethylbut-2-yn-1-aminium × 1
2CU 3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.60 Å
|
|
6U1N
GPCR-Beta arrestin structure in lipid bilayer
Deposited 2019-08-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain R
2–466(465 aa)
Fragment:M2 UNP residues 2-466 + V2 UNP residues 343-371
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
2CU 3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 4.00 Å
|
|
7T8X
Cryo-EM structure of ACh-bound M2R-Go signaling complex in S1 state
Deposited 2021-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
4–232(229 aa)
Chain A
368–466(99 aa)
|
Not recorded
|
ACH ACETYLCHOLINE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.21 Å
|
|
7T90
Cryo-EM structure of ACh-bound M2R-Go signaling complex in S2 state
Deposited 2021-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
4–232(229 aa)
Chain A
368–466(99 aa)
|
Not recorded
|
ACH ACETYLCHOLINE × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.32 Å
|
|
7T94
Cryo-EM structure of S1 state ACh-bound M2R-Go signaling complex with a PAM
Deposited 2021-12-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
4–232(229 aa)
Chain A
368–466(99 aa)
|
Not recorded
|
ACH ACETYLCHOLINE × 1
2CU 3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.16 Å
|
|
7T96
Cryo-EM structure of S2 state ACh-bound M2R-Go signaling complex with a PAM
Deposited 2021-12-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 5
PDB declaration: pentameric
|
Chain A
4–232(229 aa)
Chain A
368–466(99 aa)
|
Not recorded
|
ACH ACETYLCHOLINE × 1
2CU 3-amino-5-chloro-N-cyclopropyl-4-methyl-6-[2-(4-methylpiperazin-1-yl)-2-oxoethoxy]thieno[2,3-b]pyridine-2-carboxamide × 1
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.22 Å
|
|
8J97
Structure of Muscarinic receptor (M2R) in complex with beta-arrestin1 (Local refine, cross-linked)
Deposited 2023-05-02
|
Different construct
Different mutation/modification
Different oligomeric state
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain V
305–313(9 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.20 Å
|
|
8JAF
Structure of Muscarinic receptor (M2R) in complex with beta-arrestin1 (Local Refine, non-cross linked)
Deposited 2023-05-05
|
Different construct
Different mutation/modification
Different oligomeric state
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain V
307–313(7 aa)
|
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
No recorded non-water small molecule
|
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.4
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.10 Å
|